Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: J Cyst Fibros. 2014 Oct 23;14(3):334–340. doi: 10.1016/j.jcf.2014.10.002

Table 2.

The estimated differences between time points with standard errors and p-values for the differences. All data were first log transformed except FEV1 and 1 was added to the CRP values as one measurement was recorded as 0. All estimates are produced by a mixed effects model.

Variables aInitial-bInterim
Estimate and p-value
Interim-cFinal
Estimate and p-value
Initial-Final
Estimate and p-value
Initial-dClinic
Estimate and p-value
Sputum club cell (log ng/mL) 0.091 ± 0.155 0.557 −0.142 ± 0.201 0.481 −0.051 ± 0.196 0.795 −0.529 ± 0.167 0.001
FEV1 (absolute, L) −0.222 ± 0.035 <0.001 −0.072 ± 0.043 0.094 −0.294 ± 0.041 <0.001 −0.255 ± 0.034 <0.001
Sputum NE (log μg/mL) 0.195 ± 0.293 0.505 0.149 ± 0.419 0.723 0.344 ± 0.410 0.402 0.111 ± 0.265 0.674
Sputum IL-8 (log pg/mL) 0.100 ± 0.154 0.515 0.463 ± 0.220 0.035 0.563 ± 0.215 0.009 −0.146 ± 0.139 0.294
Plasma IL-8 (log pg/mL) 0.222 ± 0.174 0.204 −0.315 ± 0.257 0.220 −0.093 ± 0.253 0.713 0.561 ± 0.213 0.008
Plasma CRP (log mg/L) 0.327 ± 0.111 0.003 0.318 ± 0.144 0.027 0.646 ± 0.143 <0.001 0.570 ± 0.111 <0.001
a

Initial = initial pulmonary exacerbation sample during hospitalization

b

Interim = middle pulmonary exacerbation sample during hospitalization

c

Final = final exacerbation sample prior to discharge from the hospital

d

Clinic = sample collected during an outpatient clinic visit